Literature DB >> 10861059

TCR/CD3-Induced activation and binding of Emt/Itk to linker of activated T cell complexes: requirement for the Src homology 2 domain.

K A Ching1, J A Grasis, P Tailor, Y Kawakami, T Kawakami, C D Tsoukas.   

Abstract

Expressed in mast and T cells/inducible T cell tyrosine kinase (Emt/Itk), a Tec family protein tyrosine kinase, is critical for the development and activation of T lymphocytes. The mechanism through which Emt/Itk mediates its effector functions is poorly understood. In this study, we show that the Emt/Itk Src homology 2 (SH2) domain is critical for the transphosphorylation and activation of Emt/Itk catalytic activity that is mediated by TCR/CD3 engagement. Furthermore, we find that the Emt/Itk SH2 domain is essential for the formation of TCR/CD3-inducible Emt/Itk-LAT complexes, whereas the SH3 domain and catalytic activity are not required. The Emt/Itk-linker of activated T cells (LAT) complexes are biologically important because Jurkat T cells with deficient LAT expression (JCaM2) fail to increase Emt/Itk tyrosine phosphorylation upon TCR/CD3 stimulation. Confocal microscopy reveals that in activated cells, LAT complexes colocalize with TCR/CD3. The present data suggest that upon TCR/CD3 engagement, the Emt/Itk SH2 domain mediates the formation of a molecular complex containing Emt/Itk, LAT, and TCR/CD3; this complex is essential for Emt/Itk activation and function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10861059     DOI: 10.4049/jimmunol.165.1.256

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  BLNK mediates Syk-dependent Btk activation.

Authors:  Y Baba; S Hashimoto; M Matsushita; D Watanabe; T Kishimoto; T Kurosaki; S Tsukada
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

Review 2.  Positive and negative regulation of T-cell activation through kinases and phosphatases.

Authors:  Tomas Mustelin; Kjetil Taskén
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

3.  In vivo significance of ITK-SLP-76 interaction in cytokine production.

Authors:  Juris A Grasis; David M Guimond; Nicholas R Cam; Krystal Herman; Paola Magotti; John D Lambris; Constantine D Tsoukas
Journal:  Mol Cell Biol       Date:  2010-05-10       Impact factor: 4.272

4.  Expression and function of Tec, Itk, and Btk in lymphocytes: evidence for a unique role for Tec.

Authors:  Michael G Tomlinson; Lawrence P Kane; Jennifer Su; Theresa A Kadlecek; Marianne N Mollenauer; Arthur Weiss
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

5.  Disrupting the intermolecular self-association of Itk enhances T cell signaling.

Authors:  Lie Min; Wenfang Wu; Raji E Joseph; D Bruce Fulton; Leslie Berg; Amy H Andreotti
Journal:  J Immunol       Date:  2010-03-17       Impact factor: 5.422

Review 6.  T-cell signaling regulated by the Tec family kinase, Itk.

Authors:  Amy H Andreotti; Pamela L Schwartzberg; Raji E Joseph; Leslie J Berg
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-02       Impact factor: 10.005

7.  Transforming growth factor β (TGF-β) receptor signaling regulates kinase networks and phosphatidylinositol metabolism during T-cell activation.

Authors:  Richard T Cattley; Mijoon Lee; William C Boggess; William F Hawse
Journal:  J Biol Chem       Date:  2020-05-01       Impact factor: 5.157

8.  Effect of redox balance alterations on cellular localization of LAT and downstream T-cell receptor signaling pathways.

Authors:  Sonja I Gringhuis; Ellen A M Papendrecht-van der Voort; Angela Leow; E W Nivine Levarht; Ferdinand C Breedveld; Cornelis L Verweij
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

9.  The Tec family kinase Itk exists as a folded monomer in vivo.

Authors:  Qian Qi; Avery August
Journal:  J Biol Chem       Date:  2009-08-28       Impact factor: 5.157

10.  Conformational snapshots of Tec kinases during signaling.

Authors:  Raji E Joseph; Amy H Andreotti
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.